secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001493152-25-004000
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO CEO reports change of control, debt restructuring, and plans for revenue growth
--------------------------------------------------------------------------------

- Shareholders meeting Jan 17, 2025 concluded 2024 acquisition agreements, resulting in change of control of company.
- Restructured over $21M in shareholders' equity, turning deficit to meet NYSE continued listing requirements of >$4M equity.
- Acquired businesses have potential to deliver >$20M profitable net revenues per annum; focus on rural hospital and behavioral health.
- Converted approx $6M additional debt to equity via convertible preferred stock (not freely tradable).
- Plan to monetize epigenetics division (FOXO Labs) and pursue additional acquisitions in healthcare, including senior living.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225004000/0001493152-25-004000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225004000/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer